Sentences with phrase «ethical controversy»

Right now Collins, of Clarence, is under a cloud of ethical controversies including his sponsorship for a federal judgeship of John L. Sinatra Jr., the brother of a business partner and his sponsorship of legislation benefiting an Australian pharmaceutical company in which he was a leading stockholder.

Ethics is what differentiates commerce from crime, but commerce also raises lots of interesting and complex ethical controversies.

But the Illinois drama has also thrust new light on the ongoing ethical controversies of House Ways and Means Chairman Charlie Rangel.

The method has also sparked new ethical controversy.

A yearlong ethical controversy over AIDS clinical trials seemed headed toward a resolution today, as the U.S. government unveiled data from Thailand showing that short - term therapy with the antiviral drug AZT cut in half the rate at which HIV, the AIDS virus, is transmitted from mother to child at birth.

In particular, SGR is now publishing a series of briefings that offer more in - depth analysis of ethical controversies.

An increasingly long list of bizarre spending requests is adding to the ethical controversy swirling around EPA administrator Scott Pruitt.

However, it also highlights that extractives companies are particularly vulnerable to poor governance and ethical controversy, and harmful, long - lasting impacts on communities and the environment.

His explorations are rendered somewhat diffuse, moreover, by his penchant for position - taking on a wide range of philosophical, theological and ethical controversies.

Following a period of fiscal and ethical controversy, NYRA went under state control in 2012.

Republicans believe that Forrester could capitalize on the mood of change they believe is at work in the state following the ethical controversies of former governor Jim McGreevey (D) and former senator Robert Torricelli (D).

Although we agree that greater investments are needed in the clinical development of these therapies, we disagree with the authors» suggestion that, relative to embryonic stem cells, adult stem cells provide a superior vehicle for cell - based therapies because they lack tumorigenic activity, can be prepared by methods approved by the Food and Drug Administration (FDA), and have been free of ethical controversy.

At the time, many saw in Yamanaka's breakthrough a way to overcome the ethical controversies that had previously plagued research using pluripotent stem cells derived from the destruction of human embryos.

The first reports of the generation of human induced pluripotent stem cells (hiPSCs) from fibroblasts [1, 2] were greeted with great enthusiasm over their ability to mimic the properties and function of embryonic stem cells without entailing the ethical controversies and resourcing issues associated with the use of human blastocysts in derivation.